Rating History for Arcturus Therapeutics (ARCT) by B.Riley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/18/2026 | Mayank Mamtani | New Coverage | Buy (N/A) |
22.00 (N/A) |
6.63 (6.97) |
5.13% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/18/2026 | Mayank Mamtani | New Coverage | Buy (N/A) |
22.00 (N/A) |
6.63 (6.97) |
5.13% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||